medigraphic.com
ISSN 1560-4381 (Print)

2013, Number 1

<< Back Next >>

Correo Científico Médico 2013; 17 (1)

Optic Neuritis as a Presentation of Multiple Sclerosis

Cruz REM, Vargas HR, Vera BLC, Estévez DE, Villalón GG

Language: Spanish
References: 10
Page:
PDF size: 115.12 Kb.


ABSTRACT

Optic neuritis is one of the most common diseases that affects the optic nerve and is it clearly related to some specific pathologies including multiple sclerosis. Multiple sclerosis is the primary demyelinating disease of the central nervous system that affects individuals in productive stages of life. This disease has a variety regarding presentation, difficulty in diagnosing and its associated factors as well as its possible etiology. It presented a 34 - year- old female patient with puerperal optic neuritis as form of present of multiple sclerosis. The magnetic resonance imaging delivered the diagnosis.


REFERENCES

  1. Poser CM, Brinar VV. Criterios diagnósticos para la esclerosis múltiple. Rev FEDEM. 2009; 14:1–19.

  2. Pradilla G, León Sarmiento FE. Esclerosis múltiple en Colombia: cerrando la brecha. Acta Neurol Colomb. 2007; 23(1):1-5.

  3. Vizcarra Escobar D, Kawano Castillo J, Castañeda Barba C, Chereque Gutiérrez A, Tipismana Barbarán M, Bernabé Ortiz A, et al. La esclerosis múltiple es la principal enfermedad desmielinizante a nivel mundial. Rev Med Hered. 2009; 20(3):1-6.

  4. Alemany MJ. Enfermedades autoinmunes y esclerosis múltiple. Rev Neurol. 2005; 40 (10):594-7.

  5. McDonald MWI, Compstom A, Edam G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines for international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50:121-7.

  6. Bermejo PE, Oreja Guevara C, Díez Tejedor E. El dolor en la esclerosis múltiple: prevalencia, mecanismos, tipos y tratamiento. Rev Neurol. 2010; 50 (2):101-8.

  7. Díaz-Valle D, Méndez R, Arriola P, Cuiña R, Ariño M. Enfermedades sistémicas no infecciosas y uveítis. An Sist Sanit Navar. 2008; 31 (3):97-110

  8. Porras Betancourt M, Núñez Orozco L, Placencia Álvarez NI, Quiñones Aguilar S, Suárez Sauri S. Esclerosis múltiple. Rev Mex Neuroci. 2007; 8(1):57-66.

  9. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiol. 2007; 29:150-5.

  10. Pertwee RG. Cannabinoids and multiple sclerosis. Mol Neurobiol. 2007; 36:45-59.




2020     |     www.medigraphic.com